
Positive preliminary biomarker data were reported from the first cohort in the phase 1 portion of the trial.

Positive preliminary biomarker data were reported from the first cohort in the phase 1 portion of the trial.

Dave Bellevue of The Oxymorrons joins Steve to talk about his journey to mental health advocacy.

The study suggested that dermatologists in academic settings were more likely to utilize teledermatology prior to the limitations of the COVID-19 pandemic as well.

Data show at-home VA test results from printed chart, mobile phone app, and website were validated within 1 line to in-office measurements.

Dr. Ruth Benca details the newest findings from the Wake Up America: The Night & Day Impact of Insomnia survey.

The adverse event rate was 2.2% for patients with IBD following 1 dose of the vaccine.

A study highlights methods to define hydroxyurea exposure as means of understanding hematologic benefit derived from the first-line drug for children.

The study shows fenofibrate use was associated with a lower risk of progression to PDR and VTDR, but not DME alone.

Data show a combined increase in the risk of SRD, RVO, and ION associated with the use of PDE5Is in older men.

New phase 3 data found that 70% of patients with atopic dermatitis achieved EASI-75 following treatment with lebrikizumab and topical corticosteroids

A new systematic review found that patients with the dermatologic condition experienced moderate impairment of health-related quality of life and emotions.

The protocol appeared safe, with no associated increases in the incidence of hypoglycemic events during hospitalization or 30-day mortality.

Current smoking status, emergent/urgent surgery, and abdominoperineal resection were considered risk factors for total complications.

Mean follow-up IOP was similar between groups, with a median of 15.83 mm Hg among patients with glaucoma versus 14.94 mm Hg among healthy participants.

A survey analysis suggests the worst of turnover in the workforce occurred in 2020, but focus is needed to recover health care workers from specific fields.

No evidence of lower Lp(a)-associated risks in hormone therapy users versus nonusers was observed.

Conversely, age was shown to have a negative association, as did the highest category of physical activity.

Botulin toxin was first approved by the FDA in 2002 for cosmetic reasons.

Differences in rosacea subtypes were also observed regarding patient sex, continent of origin, and the year of publication.

Dr. Karan Lal provides essential information on rosacea, which the National Rosacea Society estimates to affect 16 million people in the United States.

In data presented at AAD, investigators found increased odds of GERD in patients with rosacea compared to a control group without rosacea.

The investigative team also observed a significant association between psoriasis, IBS, anxiety, and depression in patients with diabetes and rosacea.

Previous research has suggested that current rosacea therapies can also induce burning or stinging sensations in patients.

Among the different rosacea phenotypes included in the study, no statistical difference in ANAs was observed.

There is a need for new medications for depression to overcome high rates of treatment resistance.

New 5-year data raises concerns of over-diagnosis from melanoma screening.

More research is needed to identify barriers and test interventions to improve hypertension screening and CVD prevention in children with autism

The highest epidermal thickness was calculated for Asian skin at the forehead while the lowest epidermal thickness was for African skin at the dorsal forearm.

The prevalence of NAFLD in the pediatric population has increased in recent years.